Profile: Endologix, Inc. is a developer and manufacturer of minimally invasive treatments for vascular diseases. We focus on the development and marketing of patented technology for the treatment of abdominal aortic aneurysms. Our speciality product is the PowerLink® which is an endovascular shaft for abdominal aortic aneurysms. Its unibody-bifurcated design eliminates the possibility of limb detachment and provides simple delivery through a single cut down. It is a one-piece device with a main body and two limbs. The single wire construction of the main body provides durability.
The company was founded in 1992, has revenues of USD 1-5 Million, has ~120 employees and is ISO, CE certified. NASDAQ:ELGX (SEC Filings)
FDA Registration Number: 3011063223
2 Products/Services (Click for related suppliers)
|
• Endovascular Grafts for Treatment of Abdominal Aortic Aneurysm (FDA Code: MIH) |
• Percutaneous Catheter (FDA Code: DQY / 870.1250) A percutaneous catheter is a device that is introduced into a vein or artery through the skin using a dilator and a sheath (introducer) or guide wire. |